NCT Number,Study Title,Study URL,Acronym,Study Status,Brief Summary,Study Results,Conditions,Interventions,Primary Outcome Measures,Secondary Outcome Measures,Other Outcome Measures,Sponsor,Collaborators,Sex,Age,Phases,Enrollment,Funder Type,Study Type,Study Design,Other IDs,Start Date,Primary Completion Date,Completion Date,First Posted,Results First Posted,Last Update Posted,Locations,Study Documents
NCT04538664,"A Study of Combination Amivantamab and Carboplatin-Pemetrexed Therapy, Compared With Carboplatin-Pemetrexed, in Participants With Advanced or Metastatic Non-Small Cell Lung Cancer Characterized by Epidermal Growth Factor Receptor (EGFR) Exon 20 Insertions",https://clinicaltrials.gov/study/NCT04538664,PAPILLON,ACTIVE_NOT_RECRUITING,"The purpose of this study is to compare the efficacy, as demonstrated by progression-free survival (PFS), in participants treated with amivantamab in combination with chemotherapy, versus chemotherapy alone in participants with locally advanced or metastatic non-small cell lung cancer (NSCLC) characterized by EGFR Exon 20ins mutations.",YES,"Carcinoma, Non-Small-Cell Lung",DRUG: Amivantamab|DRUG: Pemetrexed|DRUG: Carboplatin|DRUG: Pemetrexed,"Progression-Free Survival (PFS) According to Response Evaluation Criteria in Solid Tumors (RECIST) Version 1.1 as Assessed by Blinded Independent Central Review (BICR), PFS was defined as the time from randomization until the date of objective disease progression based on BICR using RECIST version 1.1 or death (by any cause) in the absence of progression, whichever came first. Participants who have not progressed or have not died at the time of analysis were censored at the time of the latest date of their last evaluable RECIST version 1.1 assessment. Pharmacodynamic: Sum of diameters increased by greater than or equal to (\>=)20 percent (%) and \>=5 millimeter (mm) from nadir (including baseline if it was smallest sum)., From randomization to either disease progression or death whichever occurs first (up to 29 months)","Objective Response Rate (ORR), Up to 5 years 3 months|Duration of Response (DoR), Up to 5 years 3 months|Overall Survival (OS), Up to 5 years 3 months|Time to Subsequent Therapy (TST), Up to 5 years 3 months|Progression-Free Survival After First Subsequent Therapy (PFS2), Up to 5 years 3 months|Time to Symptomatic Progression (TTSP), Up to 5 years 3 months|Number of Participants Treatment-emergent Adverse Events (TEAEs), From Day 1 to 5 years 2 months|Number of Participants TEAEs With Severity, From Day 1 to 5 years 2 months|Number of Participants With Clinical Laboratory Abnormalities, Up to 5 years 3 months|Number of Participants With Vital Signs Abnormalities, Up to 5 years 3 months|Number of Participants With Physical Examination Abnormalities, Up to 5 years 3 months|Serum Concentration of Amivantamab, Day 1 (Cycles 1, 2, 3, 5, 7, 9, 11, 13), Day 2 (Cycle 1)|Number of Participants With Anti-Amivantamab Antibodies, Day 1 (Cycles 1, 2, 3, 5, 7, 9, 11, 13), Day 2 (Cycle 1)|Change From Baseline in European Organization of Research and Treatment of Cancer Quality of Life Questionnaire Core 30 (EORTC-QLQ-C30), From baseline to 5 years 3 months|Change From Baseline in Patient Reported Outcomes Measurement Information System-Physical Function (PROMIS-PF), From baseline to 5 years 3 months",,"Janssen Research & Development, LLC",,ALL,"ADULT, OLDER_ADULT",PHASE3,308,INDUSTRY,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT,CR108850|2020-000633-40|61186372NSC3001|2023-506033-29-00,2020-10-13,2023-05-03,2026-01-31,2020-09-04,2024-05-29,2025-04-01,"City of Hope, Duarte, California, 91010, United States|University of California Irvine, Orange, California, 92868, United States|UCLA, Santa Monica, California, 90404, United States|Georgetown University Hospital, Washington, District of Columbia, 20007, United States|H. Lee Moffitt Cancer & Research Institute, Tampa, Florida, 33612, United States|University Cancer And Blood Center LLC, Athens, Georgia, 30607, United States|Henry Ford Hospital, Detroit, Michigan, 48202, United States|Washington University Medical Center, Saint Louis, Missouri, 63110, United States|Regional Cancer Care Associates LLC, East Brunswick, New Jersey, 08816, United States|Langone Health at NYC University, NYU School of Medicine, New York, New York, 10016, United States|Columbia University Medical Center, New York, New York, 10032, United States|Providence Portland Medical Center, Portland, Oregon, 97213, United States|Sanford Health, Sioux Falls, South Dakota, 57104, United States|Texas Oncology Pa, Tyler, Texas, 75702, United States|Utah Cancer Specialists, Salt Lake City, Utah, 84106, United States|Virginia Cancer Specialists, Fairfax, Virginia, 22031, United States|Blue Ridge Cancer Care, Salem, Virginia, 24153, United States|Chris O'Brien Lifehouse, Camperdown, 2050, Australia|St George Hospital, Kogarah, 2217, Australia|Cabrini Medical Centre, Malvern, 3144, Australia|Sir Charles Gairdner Hospital, Nedlands, 6009, Australia|UZ Leuven, Leuven, 3000, Belgium|Algemeen Ziekenhuis Delta, Roeselare, 8800, Belgium|CHU UCL Namur - Site Godinne, Yvoir, 5530, Belgium|Fundacao Pio XII, Barretos, 14784-400, Brazil|Cetus Oncologia, Belo Horizonte, 30110-017, Brazil|Ynova Pesquisa Clinica, Florianopolis, 88020-210, Brazil|Oncosite - Centro de Pesquisa Clínica em Oncologia Ltda, Ijui, 98700-000, Brazil|Liga Norte Riograndense Contra O Cancer, Natal, 59062 000, Brazil|UPCO Unidade de Pesquisa Clinica em Oncologia, Pelotas, 96020 080, Brazil|Irmandade Santa Casa de Misericordia de Porto Alegre, Porto Alegre, 90020-090, Brazil|Uniao Brasileira de Educacao e Assistencia Hospital Sao Lucas da PUCRS, Porto Alegre, 90610-000, Brazil|Ministerio da Saude Instituto Nacional do Cancer, Rio De Janeiro, 20231 050, Brazil|Oncoclinicas Rio de Janeiro S A, Rio de Janeiro, 22 250 905, Brazil|Instituto D Or de Pesquisa e Ensino IDOR, Rio de Janeiro, 22281 100, Brazil|Fundacao Faculdade de Medicina - Instituto do Cancer do Estado de Sao Paulo, Sao Paulo, 01246 000, Brazil|Fundacao Antonio Prudente A C Camargo Cancer Center, Sao Paulo, 01509 900, Brazil|Núcleo de Pesquisa São Camilo, Sao Paulo, 04014-002, Brazil|IOS - Instituto de Oncologia de Sorocaba Dr. Gilson Delgado, Sorocaba, 18030-075, Brazil|Hospital Evangélico de Cachoeiro de Itapemirim, Vitoria, 29308-014, Brazil|The Ottawa Hospital Cancer Centre, Ottawa, Ontario, K1H 8L6, Canada|Sunnybrook Health Sciences Centre, Toronto, Ontario, M4N 3M5, Canada|McGill University Health Centre, Montreal, Quebec, H4A 3J1, Canada|Beijing Cancer Hospital, Beijing, 100142, China|Chinese PLA General Hospital, Beijing, 100853, China|Beijing Chest hospital, Capital medical university, Beijing, 101199, China|Peking University International Hospital, Beijing, 102206, China|Jilin cancer hospital, Changchun, 130000, China|Hunan Cancer hospital, Changsha, 410013, China|The First People's Hospital Of Changzhou, Changzhou, 213003, China|West China Hospital Sichuan University, Chengdu, 610041, China|Chongqing University Cancer Hospital, Chongqing, 400030, China|Fujian Medical University Union Hospital, Fuzhou, 350001, China|The First Affiliated Hospital Sun Yat sen University, Guang Zhou, 510080, China|Zhejiang Cancer Hospital, Hang Zhou, 310022, China|The First Affiliated Hospital Zhejiang University College of Medicine, Hangzhou, 310003, China|The Second Affiliated Hospital of Zhejiang University College of Medicine, Hangzhou, 310009, China|Sir Run Run Shaw Hospital Zhejiang University School of Medicine, Hangzhou, 310016, China|Harbin medical university cancer hospital, Harbin, 150000, China|Taizhou Hospital of Zhejiang Province, Linhai, 317000, China|Nanjing Drum Tower Hospital, Nanjing, 210031, China|Shanghai Chest Hospital, Shanghai, 200030, China|Fudan University Shanghai Cancer Center, Shanghai, 200032, China|Shanghai East Hospital, Shanghai, 200123, China|Shanghai Pulmonary Hospital, Shanghai, 200433, China|Shengjing Hospital Of China Medical University, Shenyang, 110004, China|Cancer hospital Chinese Academy of Medical Sciences, Shenzhen Center, Shenzhen, 518116, China|Tianjin Medical University General Hospital, Tianjin, 300052, China|Weifang People's Hospital, Weifang, 261000, China|TongJi Hospital of TongJi Medical College of Huazhong University of Science & Technology, Wuhan, 430030, China|Hospital of Jiangnan University, Wuxi, 214122, China|The First Affiliated Hospital of Xian Jiaotong University, XI An, 710061, China|Yantai Yuhuangding Hospital, Yantai, 264000, China|Henan Cancer Hospital, Zhengzhou, 450008, China|Institut Bergonie, Bordeaux, 33000, France|Hospices Civils de Lyon HCL, Bron, 69500, France|Centre Georges Francois Leclerc, Dijon, 21000, France|Centre Hospitalier Le Mans, le mans Cedex 9, 72037, France|CHR Hôpital Calmette, Lille CEDEX, 59037, France|CHU Nantes - Hopital Nord Laënnec, NANTES cedex 1, 44093, France|Institut Curie, Paris, 75005, France|CHU Bordeaux, Pessac, 33604, France|HIA Begin, Saint Mande, 94163, France|Zentralklinik Bad Berka GmbH, Bad Berka, 99437, Germany|Evangelische Lungenklinik Berlin, Berlin, 13125, Germany|Asklepios Klinik Gauting GmbH - Asklepios Fachkliniken Munchen-Gauting, Gauting, 82131, Germany|Thoraxklinik am Universitatsklinikum Heidelberg, Heidelberg, 69126, Germany|Onkologische Schwerpunktpraxis, Heilbronn, 74072, Germany|Universitaetsklinikum Koeln, Koeln, 50937, Germany|Kliniken der Stadt Koeln gGmbH, Koeln, 51109, Germany|Bethanien Krankenhaus, Moers, 47441, Germany|Pius-Hospital Oldenburg, Oldenburg, 26121, Germany|Oncologianova GmbH, Recklinghausen, 45659, Germany|Orszagos Koranyi Tbc es Pulmonologiai Intezet, Budapest, H-1529, Hungary|Mátrai Gyógyintézet-Bronchológia, Gyöngyös, 3233, Hungary|Fejer Varmegyei Szent Gyorgy Egyetemi Oktatokorhaz, Szekesfehervar, 8000, Hungary|Markusovszky Egyetemi Oktatokorhaz, Szombathely, 9700, Hungary|Tudogyogyintezet Torokbalint, Torokbalint, 2045, Hungary|Basavatarakam Indo-American Hospital, Hyderabad, 500034, India|Tata Medical Center, Kolkata, 700160, India|Tata Memorial Hospital, Mumbai, 400012, India|HCG Manavta Cancer Centre, Nasik, 422002, India|Rajiv Gandhi Cancer Institute & Research Centre, New Delhi, 110085, India|Noble Hospital Pvt Ltd, Pune, 411013, India|Shaare Zedek Medical Center, Jerusalem, 91031, Israel|Hadassah Medical Center, Jerusalem, 9112001, Israel|Meir Medical Center, Kfar Saba, 44281, Israel|Rabin Medical Center, Petah Tikva, 49100, Israel|Tel Aviv Sourasky Medical Center, Tel-Aviv, 6423906, Israel|A O U Sant Orsola Malpighi, Bologna, 40138, Italy|Azienda Ospedaliero Univ. Policlinico Gaspare Rodolico, Catania, 95123, Italy|Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori, Meldola, 47014, Italy|Fondazione IRCCS Ca Granda Ospedale Maggiore Policlinico, Milano, 20122, Italy|IRCCS Ospedale San Raffaele, Milano, 20132, Italy|Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, 20133, Italy|San Gerardo Hospital, Monza, 20052, Italy|Ospedale S. Maria Delle Croci, Ravenna, 48121, Italy|Irccs Gemelli, Roma, 00168, Italy|Istituto Clinico Humanitas, Rozzano, 20089, Italy|Juntendo University Hospital, Bunkyo Ku, 113 8431, Japan|Saitama Medical University International Medical Center, Hidaka, 350-1298, Japan|National Hospital Organization Himeji Medical Center, Himeji, 670-8520, Japan|Kansai Medical University Hospital, Hirakata, 573-1191, Japan|Kanazawa University Hospital, Kanazawa, 920 8641, Japan|National Cancer Center Hospital East, Kashiwa, 277 8577, Japan|Kishiwada City Hospital, Kishiwada, 596-8501, Japan|Kobe City Medical Center General Hospital, Kobe, 650-0047, Japan|Kurashiki Central Hospital, Kurashiki, 710-8602, Japan|Kurume University Hospital, Kurume, 830-0011, Japan|Matsusaka Municipal Hospital, Matsusaka, 515-8544, Japan|Aichi Cancer Center Hospital, Nagoya Shi, 464 8681, Japan|National Hospital Organization Nagoya Medical Center, Nagoya-shi, 460-0001, Japan|Niigata Cancer Center Hospital, Niigata, 951-8566, Japan|Kindai University Hospital, Osaka Sayama shi, 589 8511, Japan|Kitasato University Hospital, Sagamihara, 252-0375, Japan|Hokkaido University Hospital, Sapporo-shi, 060-8648, Japan|Iwate Medical University Hospital, Shiwa-gun, 028-3695, Japan|Shizuoka Cancer Center, Shizuoka, 411 8777, Japan|The Cancer Institute Hospital of JFCR, Tokyo, 135 8550, Japan|Ehime University Hospital, Toon-shi, 791-0295, Japan|Wakayama Medical University Hospital, Wakayama, 641 8510, Japan|National Hospital Organization Yamaguchi Ube Medical Center, Yamaguchi, 755-0241, Japan|Inje University Haeundae Paik Hospital, Busan, 48108, Korea, Republic of|National Cancer Center, Gyeonggi-do, 10408, Korea, Republic of|GyeongSang National University Hospital, Gyeongsangnam-do, 52727, Korea, Republic of|Chonnam National University Hwasun Hospital, Jeollanam-do, 58128, Korea, Republic of|Seoul National University Bundang Hospital, Seongnam-si, 13620, Korea, Republic of|Korea University Anam Hospital, Seoul, 02841, Korea, Republic of|Kangbuk Samsung Hospital, Seoul, 03181, Korea, Republic of|Severance Hospital Yonsei University Health System, Seoul, 03722, Korea, Republic of|Asan Medical Center, Seoul, 05505, Korea, Republic of|Samsung Medical Center, Seoul, 06351, Korea, Republic of|The Catholic University of Korea Seoul St Mary s Hospital, Seoul, 06591, Korea, Republic of|Hospital Pulau Pinang, George Town, 10990, Malaysia|Hospital Sultan Ismail, Johor Bahru, 81100, Malaysia|Hospital Kuala Lumpur, Kuala Lumpur, 50586, Malaysia|University Malaya Medical Centre, Kuala Lumpur, 59100, Malaysia|Centro Oncologico de Chihuahua, Chihuahua, 31217, Mexico|Mexico Centre for Clinical Research, S.A. de C.V., Ciudad de Mexico, 03100, Mexico|Médica Sur, Ciudad de Mexico, 14050, Mexico|Instituto Nacional de Cancerologia, Ciudad de Mexico, 14080, Mexico|Hospital Civil de Guadalajara Fray Antonio Alcalde, Guadalajara, 44280, Mexico|Health Pharma Professional Research, Mexico, 03100, Mexico|i Can Oncology Center, Monterrey, 64710, Mexico|Oncologia Integral Satelite, Naucalpan, 53100, Mexico|Centrum Onkologii im Prof F Lukaszczyka, Bydgoszcz, 85 796, Poland|Uniwersyteckie Centrum Kliniczne, Gdansk, 80 214, Poland|Szpitale Pomorskie Sp z o o, Gdynia, 81 519, Poland|Warminsko-Mazurskie Centrum Chorob Pluc w Olsztynie, Olsztyn, 10-357, Poland|Private Specialist Hospitals - MedPolonia, Poznan, 60-693, Poland|Narodowy Instytut Onkologii im Marii Sklodowskiej Curie Panstwowy Instytut Badawczy, Warszawa, 02-781, Poland|Hosp. Cuf Descobertas, Lisboa, 1998-018, Portugal|Uls Sao Jose - Hosp. Sto Antonio Dos Capuchos, Lisboa, G1R 2J6, Portugal|Centro Hospitalar Universitario do Porto, EPE, Porto, 4099-001, Portugal|Instituto Portugues de Oncologia, Porto, 4200-072, Portugal|Centro Hospitalar de Vila Nova de Gaia Espinho E P E, Vila Nova de Gaia, 4434 502, Portugal|Pan American Center for Oncology Trials LLC, Rio Piedras, 00935, Puerto Rico|Irkutsk Regional Oncology Dispensary, Irkutsk, 664035, Russian Federation|Moscow City Oncology Hospital № 62, Krasnogorsk, 143423, Russian Federation|Krasnoyarsk Regional Oncology Dispensary, Krasnoyarsk, 660133, Russian Federation|Leningrad Regional Oncology Dispensary, Kuzmolovsky, 188663, Russian Federation|MCK, Moscow, 115533, Russian Federation|City Clinical Hospital #1, Nalchik, 360000, Russian Federation|Nizhny Novgorod Regional Oncological Dispensary, Nizhniy Novgorod, 603000, Russian Federation|N.N. Petrov Research Institute Of Oncology, Saint Petersburg, 197758, Russian Federation|Leningrad Regional Clinical Hospital, Saint-Petersburg, 194291, Russian Federation|Oncology Medical Clinics AV Medical group, St-Petersburg, 196006, Russian Federation|Tomsk Cancer Research Institute, Tomsk, 634050, Russian Federation|Bashkir State Medical University, Ufa, 450083, Russian Federation|Yaroslavl Regional Clinical Oncology Hospital, Yaroslavl, 150054, Russian Federation|Hosp Univ A Coruna, A Coruna, 15006, Spain|Inst. Cat. D'Oncologia-Badalona, Badalona, 08916, Spain|Hosp. de La Santa Creu I Sant Pau, Barcelona, 08025, Spain|Hosp. Univ. Quiron Dexeus, Barcelona, 08028, Spain|Hosp Univ Vall D Hebron, Barcelona, 08035, Spain|Hosp. Univ. de Burgos, Burgos, 09003, Spain|Hosp. Gral. Univ. Gregorio Maranon, Madrid, 28007, Spain|Hosp. Univ. Ramon Y Cajal, Madrid, 28034, Spain|Hosp. Univ. 12 de Octubre, Madrid, 28041, Spain|Hosp. Univ. La Paz, Madrid, 28046, Spain|Hosp. Univ. Pta. de Hierro Majadahonda, Majadahonda, 28222, Spain|Hosp Virgen de La Victoria, Málaga, 29010, Spain|Clinica Univ. de Navarra, Pamplona, 31008, Spain|Hosp. Virgen Del Rocio, Seville, 41013, Spain|Hosp. Clinico Univ. Lozano Blesa, Zaragoza, 50009, Spain|Kaohsiung Medical University Chung Ho Memorial Hospital, Kaohsiung, 807, Taiwan|Chang Gung Medical Foundation, Kaohsiung, 833, Taiwan|Taipei Medical University Shuang Ho Hospital, New Taipei, 23561, Taiwan|Chung Shan Medical University Hospital, Taichung, 402, Taiwan|China Medical University Hospital, Taichung, 40447, Taiwan|National Taiwan University Hospital, Taipei City, 10002, Taiwan|Phramongkutklao Hospital and Medical College, Bangkok, 10400, Thailand|Siriraj Hospital, Bangkok, 10700, Thailand|Songklanagarind Hospital, Prince of Songkla University, Songkla, 90110, Thailand|Adana City Hospital, Adana, 01060, Turkey|Başkent University Medical Faculty Adana Application and Research Center, Adana, 01250, Turkey|Gazi University Hospital, Ankara, 6560, Turkey|Ankara Bilkent City Hospital, Ankara, 6800, Turkey|Trakya University Medical Faculty, Edirne, 22030, Turkey|Istanbul Universitesi Cerrahpasa Tip Fakultesi Ic Hastaliklari Anabilim Dali Medikal Onkoloji Bd, Istanbul, 34098, Turkey|Medipol Mega University Hospital, Istanbul, 34214, Turkey|Goztepe Prof Dr Suleyman Yalcin Sehir Hastanesi, Istanbul, 34722, Turkey|Izmir Medical Park Hospital, Izmir, 35580, Turkey|Dnipropetrovsk State Medical Academy, Dnipropetrovsk City Multifield Clinical Hospital # 4, Dnipro, 49102, Ukraine|Medical Center 'Ok Clinic' of LLC 'International Institute of Clinical Studies', Kyiv, 02091, Ukraine|National Cancer Institute, Kyiv, 03022, Ukraine|Edinburgh Cancer Centre Western General, Edinburgh, EH4 2XU, United Kingdom|The Royal Marsden NHS Trust, London, SW3 6JJ, United Kingdom|The Royal Marsden NHS Trust, Sutton, SM2 5PT, United Kingdom","Study Protocol, https://cdn.clinicaltrials.gov/large-docs/64/NCT04538664/Prot_000.pdf|Statistical Analysis Plan, https://cdn.clinicaltrials.gov/large-docs/64/NCT04538664/SAP_001.pdf"
